1. Home
  2. SRTA vs HQL Comparison

SRTA vs HQL Comparison

Compare SRTA & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

N/A

Current Price

$4.65

Market Cap

472.4M

Sector

N/A

ML Signal

N/A

Logo abrdn Life Sciences Investors Shares of Beneficial Interest

HQL

abrdn Life Sciences Investors Shares of Beneficial Interest

N/A

Current Price

$16.66

Market Cap

492.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SRTA
HQL
Founded
2014
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
472.4M
492.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SRTA
HQL
Price
$4.65
$16.66
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.63
N/A
AVG Volume (30 Days)
807.8K
124.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
11.56%
EPS Growth
N/A
N/A
EPS
N/A
0.79
Revenue
N/A
N/A
Revenue This Year
$37.89
N/A
Revenue Next Year
$14.33
N/A
P/E Ratio
$9.88
$21.35
Revenue Growth
N/A
N/A
52 Week Low
$3.85
$10.55
52 Week High
$6.02
$17.80

Technical Indicators

Market Signals
Indicator
SRTA
HQL
Relative Strength Index (RSI) 49.13 49.32
Support Level $4.26 $16.40
Resistance Level $5.15 $17.51
Average True Range (ATR) 0.24 0.28
MACD 0.04 0.02
Stochastic Oscillator 51.65 66.67

Price Performance

Historical Comparison
SRTA
HQL

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.

About HQL abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.

Share on Social Networks: